Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04SCQ
|
||||
| Former ID |
DNC010216
|
||||
| Drug Name |
4,4-Diphenylbutan-1-amine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530331] | ||
| Formula |
C16H19N
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)C(CCCN)C2=CC=CC=C2
|
||||
| InChI |
1S/C16H19N/c17-13-7-12-16(14-8-3-1-4-9-14)15-10-5-2-6-11-15/h1-6,8-11,16H,7,12-13,17H2
|
||||
| InChIKey |
MAAQGZFMFXQVOG-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Histamine H1 receptor | Target Info | Inhibitor | [530331] | |
| 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [530331] | ||
| WikiPathways | Monoamine GPCRs | ||||
| GPCRs, Class A Rhodopsin-like | |||||
| IL-4 Signaling Pathway | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
| Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| SIDS Susceptibility Pathways | |||||
| GPCR downstream signaling | |||||
| GPCRs, Other | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.